"Contraceptives, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
| Descriptor ID |
D003276
|
| MeSH Number(s) |
D27.505.696.875.360.276.210 D27.505.954.705.360.276.210
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Contraceptives, Oral".
Below are MeSH descriptors whose meaning is more specific than "Contraceptives, Oral".
This graph shows the total number of publications written about "Contraceptives, Oral" by people in this website by year, and whether "Contraceptives, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 3 | 4 |
| 2001 | 0 | 2 | 2 |
| 2003 | 1 | 1 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Contraceptives, Oral" by people in Profiles.
-
Zeiger JS, Styklunas GM, King CG, Mercier RJ. Practices and attitudes of providers towards continuity of care with patients using prescription contraceptives. J Obstet Gynaecol. 2022 Nov; 42(8):3701-3705.
-
Brown EJ, Deshmukh P, Antell K. Contraception Update: Oral Contraception. FP Essent. 2017 Nov; 462:11-19.
-
Park B, Park S, Shin HR, Shin A, Yeo Y, Choi JY, Jung KW, Kim BG, Kim YM, Noh DY, Ahn SH, Kim JW, Kang S, Kim JH, Kim TJ, Kang D, Yoo KY, Park SK. Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea. BMC Cancer. 2016 Jan 06; 16:5.
-
Urisman A, Leard LE, Nathan M, Elicker BM, Hoopes C, Kukreja J, Jones KD. Rapidly progressive pulmonary venoocclusive disease in young women taking oral contraceptives. J Heart Lung Transplant. 2012 Sep; 31(9):1031-6.
-
Perriera LK, Greenfield M. When parents do not want their daughters on birth control pills: tips for navigating a difficult clinical situation. J Pediatr Adolesc Gynecol. 2012 Feb; 25(1):79-81.
-
Orlin A, Orlin SE, Makar GA, Bunya VY. Presumed corneal copper deposition and oral contraceptive use. Cornea. 2010 Apr; 29(4):476-8.
-
Meldrum DR, Chang RJ, de Ziegler D, Schoolcraft WB, Scott RT, Pellicer A. Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs? Fertil Steril. 2009 Jul; 92(1):13-8.
-
Vargas BB, Dodick DW, Wingerchuk DM, Demaerschalk BM. Migraine with and without aura and risk for cardiovascular disease. Curr Atheroscler Rep. 2008 Oct; 10(5):427-33.
-
Meldrum DR, Scott RT, Levy MJ, Alper MM, Noyes N. Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss. Fertil Steril. 2009 May; 91(5):1963-5.
-
Silberstein SD, Goldberg J. Menstrually related migraine: breaking the cycle in your clinical practice. J Reprod Med. 2007 Oct; 52(10):888-95.